Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02257866 · ClinicalTrials.gov registry record
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
A clinical trial of Giant Cell Arteritis and Takayasu's Arteritis, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT02257866 is a study of Giant Cell Arteritis and Takayasu's Arteritis that is actively recruiting participants, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 4,000 participants, above the 479-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (735% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02257866, a study of Giant Cell Arteritis and Takayasu's Arteritis, is actively recruiting participants, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the disease affects them. Objective: \- To learn the signs, symptoms, imaging tests, genetic markers, and blood tests that can help identify people with vasculitis and predict what will happen to them over time. Eligibility: * People age 3 and older who have or are thought to have vasculitis, or are related to someone with it. * Healthy volunteers. Design: * Participants will be evaluated by a doctor who has expertise caring for patients with vasculitis. * Participants will give a blood sample. Some will give a urine sample. * Some participants may have brushings or biopsies taken from the inside lining of the nose. * Images of participants blood vessels may be taken using scans. For some scans, participants will lie on a table that moves in and out of a cylinder that takes pictures. For some scans, a contrast agent may be injected into an arm vein. Other scans may use a radioactive form of sugar. Healthy minors will not have scans. * Some participants will answer questionnaires. - Some participants will have their tests done at NIH. Others will have their doctor take the blood, saliva, or cheek swab samples and send them to NIH. * Some participants will have one visit lasting 1-2 (but sometimes up to 4) days. Some participants may have follow-up visits every 3 - 6 months, indefinitely.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2014-09-29 |
| Est. Completion | 2050-01-01 |
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)93 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02257866
The ClinicalTrials.gov registry entry for NCT02257866 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 479-participant average among 7 other Giant Cell Arteritis trials with a reported enrollment target (735% higher). The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Giant Cell Arteritis appearing as the primary indexed condition, and to 0 interventions.
NCT02257866 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02257866 about?
NCT02257866 is a clinical study titled "Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis". Background: \- Vasculitis is a group of diseases that inflame and damage blood vessels and tissue. It can cause many medical problems. Few tests can diagnose the disease, and none can reliably predict a relapse. Researchers want to study people s genes and follow people over time to see how the dis...
What is the current status of trial NCT02257866?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2014-09-29. Estimated completion is 2050-01-01.
What conditions does trial NCT02257866 study?
This clinical trial studies the following conditions: Giant Cell Arteritis, Takayasu's Arteritis, Relapsing Polychondritis, Polyarteritis Nodosa, ANCA-Associated Vasculitis.
Who is sponsoring clinical trial NCT02257866?
This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02257866 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Giant Cell Arteritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vascular MRI Evaluation in Giant Cell Arteritis (VEGA)
RECRUITING
-
One-Time DNA Study for Vasculitis
RECRUITING
-
VCRC Tissue Repository
RECRUITING
-
Abatacept for the Treatment of Giant Cell Arteritis
RECRUITING · Phase 3
-
Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
COMPLETED · Phase 2
-
Vasculitis Illness Perception (VIP) Study
COMPLETED
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.